Spring is just around the corner, and The Aesthetic Society is already experiencing renewed energy and new growth. I wanted to answer some questions about what’s next.
It is just about two months from The Aesthetic MEET, and we have no lack of education, networking, and fun for you to take part in while you are in Boston. There are many opportunities to engage with and support The Aesthetic Foundation during The MEET, and I look forward to connecting and sharing all that has been accomplished with you.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
Do you have an idea for a study but don’t where to start or how to finance it? The Aesthetic Foundation has awarded over $3 Million dollars to aesthetic surgery research since it was founded in 1993.